N/A
N=313
Linking Inter-professional Newborn and Contraception Care
Family Planning · Contraception · PostPartum
Bottom Line
View on ClinicalTrials.gov: NCT04092530 ↗Enrolled (actual)
313
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Number of Patients Who Receive Contraception by Two Months Postpartum — 474; 339 Participants — p=0.12
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- LINCC intervention - enable co-schedule feature (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Rush University Medical Center
- Primary completion
- Jun 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients Who Receive Contraception by Two Months Postpartum |
474; 339 | 0.12 |
| SECONDARY Number of Patients Who Receive Contraception by Six Months Postpartum |
595; 436 | 0.33 |
| SECONDARY Number of Patients Who Present With a Short Inter-pregnancy Interval Pregnancies |
67; 55 | 0.88 |
Summary
Pregnancies conceived within 18 months of a prior delivery (termed short inter-pregnancy interval [IPI]) place mothers and infants at high risk for poor health outcomes and affect nearly one third of women in the U.S. Rates of postpartum (PP) contraception use remain low, particularly among low-income minority women, leading to high rates of short IPI pregnancies. This proposed study aims to address the gap in the current model of PP contraception care, by developing and implementing a novel approach to link (co-schedule) PP contraception care with newborn well-baby care with the goal of improving access to timely PP contraception.
Eligibility Criteria
Inclusion Criteria
- Eligible participants include women presenting with their infants at one of the 7 chosen CHC sites for their first WBV (typically 3-5 days after delivery).
Exclusion Criteria
- Women will be excluded if they had a tubal ligation or a long acting reversible contraception planned immediately after delivery. Additionally, women will be excluded if they needed an emergency hysterectomy due to life threatening bleeding during delivery. Any male patients will be excluded from the study because the study outcomes of contraceptive method use and pregnancy status are not applicable to males.
Data sourced from ClinicalTrials.gov (NCT04092530). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.